This evening, I got my latest Short-Term Update from Elliott Wave International, and this graph jumped out at me: We seem to be back in “real soon now” mode (e.g. “this insane countertrend rally will stop and we will get sinking
March 16, 2016
(I’m back in the turret briefly, but my hands are failing me limiting my typing, so this report is shortened.) There’s a lot of spin (um, lying?) going on with the Fed’s announcement Wednesday. It’s consistent with past comments and
I have been asked the same question many, many times: Why couldn’t you find these stocks much earlier? Well I’m listening and now using Barchart to find stocks much earlier by using more short term screening criteria. Today I used
Gold: With Gold rallying on Wednesday, we expect more upside pressure in the days ahead. To hold on to its downside pressure, further decline is envisaged. On the downside, support comes in at the 1,220.00 level where a break will
Economic growth and higher wages historically weren’t always associated, at least for decades (typically before the Gold standard was dropped and global growth expanded, largely -in time- at the expense of American workers and our industrial expansion), with ‘inflation’ as
TDC Note – Be sure and catch one of my first interviews, with the one and only Michael Noonan, from June 2014 – LINK I like both gold and silver. Both have been money, real money, depending on who you ask,
Mohamed El-Erian, former PIMCO guru and current Allianz economic adviser, warns that corporate cash, now being hoarded, must be unlocked for growth to take place. Otherwise he fears political collapse and economic demise. He rejects the concept that people’s QE
Today’s low oil prices are probably not the result, even in part, of elderly men ruling over the world’s major energy-exporting nations. Still, it may be worth noting that the royal sons of Saudi Arabia’s modern founder Abdulaziz bin Saud
Shares of Vitae Pharmaceuticals (VTAE) are up almost 50% after hours after the company announced positive proof-of-concept phase 2a results in patients with moderate to severe psoriasis. The company’s drug used in the study is known as VTP-43742. Psoriasis is
If there is any doubt as to the confusion inside the FOMC, one needs only to examine its models. The latest updated projections make a full mockery of both monetary policy and the theory that guides it. Ferbusand the rest don’t
